scispace - formally typeset
R

Ruisheng Zhang

Researcher at Lanzhou University

Publications -  13
Citations -  689

Ruisheng Zhang is an academic researcher from Lanzhou University. The author has contributed to research in topics: Quantitative structure–activity relationship & Support vector machine. The author has an hindex of 9, co-authored 13 publications receiving 647 citations.

Papers
More filters
Journal ArticleDOI

Comparative study of QSAR/QSPR correlations using support vector machines, radial basis function neural networks, and multiple linear regression.

TL;DR: The results indicate that SVM can be used as an alternative powerful modeling tool for QSAR studies and is comparable or superior to those obtained by MLR and RBFNN.
Journal ArticleDOI

Diagnosing breast cancer based on support vector machines.

TL;DR: It can be concluded that nine samples could be mislabeled from the comparison of several machine learning techniques.
Journal ArticleDOI

QSAR models for the prediction of binding affinities to human serum albumin using the heuristic method and a support vector machine.

TL;DR: The specific information described by the heuristic linear model could give some insights into the factors that are likely to govern the binding affinity of the compounds and be used as an aid to the drug design process; however, the prediction results of the nonlinear SVM model seem to be better than that of the HM.
Journal ArticleDOI

Receptor- and ligand-based 3D-QSAR study for a series of non-nucleoside HIV-1 reverse transcriptase inhibitors.

TL;DR: It is shown that for 2-amino-6-arylsulfonylbenzonitriles inhibitors to have appreciable inhibitory activity, bulky and hydrophobic groups in 3- and 5- position of the B ring are required and H-bond donor groups in 2-position of the A ring are also favorable to activity.
Journal ArticleDOI

QSAR models for 2-amino-6-arylsulfonylbenzonitriles and congeners HIV-1 reverse transcriptase inhibitors based on linear and nonlinear regression methods.

TL;DR: A quantitative structure-activity relationship study of a series of HIV-1 reverse transcriptase inhibitors and their thio and sulfinyl congeners showed that PPR and SVM models provided powerful capacity of prediction.